4 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
HF outcomes in HFrEF ... on GDMT, with or ... HF outcomes in HFrEF ... SGLT2 #inhibitors #EBM ... visualabstract #table
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... ; HFpEF, heart failure ... ejection fraction; HFrEF ... #CHF #Congestive
Pathophysiological mechanisms of diastolic heart failure HFpEF and possible therapeutic interventions.
Hypertension → Overload
Diabetes → Oxidative stress,
diastolic heart failure ... HFpEF and possible ... RAGE activation CAD ... #heartfailure #dchf ... #hfpef #pathophysiology
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
in Heart Failure ... mortality and CV ... #deficiency #CHF ... #HFrEF #heartfailure ... #diagnosis #management